Our mission is to enable the early, accurate, and widely accessible detection of renal system diseases, including bladder, kidney, and prostate cancers, by assessing specific biomarkers found in urine. EIG believes that earlier detection yields better outcomes and focuses on developing highly sensitive, accurate, and non-invasive diagnostic tests for early diagnosis and management care of cancer.